Transmembrane T-cell receptor peptides inhibit B- and natural killer-cell function

Area of Science:

• Immunology
• Molecular Biology
• Pharmacology

Background:

• A synthetic hydrophobic peptide, core peptide (CP), derived from the T-cell receptor (TCR) alpha chain, demonstrates T-cell-mediated inflammation inhibition.
• CP contains positively charged amino acids, lysine and arginine, crucial for its function.

Purpose of the Study:

• Investigate the specificity of CP on lymphocyte function.
• Determine the mechanism of CP's inhibitory effects.
• Explore CP's potential as a therapeutic anti-inflammatory peptide.

Main Methods:

• Assessed CP's effect on interleukin-2 production in T cells and natural killer (NK) cell cytotoxicity.
• Evaluated CP's impact on B-cell proliferation at varying concentrations.
• Utilized trypan blue, propidium iodide staining, and transmission electron microscopy to assess cytotoxicity and membrane integrity.
• Synthesized and tested CP analogues with altered amino acid composition and charge distribution.

Main Results:

• CP (10 microm) significantly inhibited T cell interleukin-2 production and NK cell cytotoxicity (46-58%).
• CP did not affect B-cell proliferation at 10 microm but suppressed it at 50 microm.
• No evidence of membrane pore formation or cytotoxicity was observed.
• CP analogues lacking specific charge interactions or structural integrity showed no effect on lymphocyte function.

Conclusions:

• CP's immuno-inhibitory effects are dependent on its structure and charge interactions.
• CP may target common signaling molecules across T cells, B cells, and NK cells.
• CP holds potential as a novel therapeutic agent for anti-inflammatory treatments.